US 7,732,626 B2 · Fused cyclic compounds

Abstract

The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.

Claims1

Dependent claims

[(3S)-6-({2′,6′-Dimethyl-4′-[3-(methylsulfonyl)propoxy]biphenyl-3-yl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid or a salt thereof.

Dependencies are inferred from the claim text.

Facts

Application

12/308,699Filed 26 Jun 2007

Priority

JP 2006-17709927 Jun 2006

Published

US 2010/0004312 A17 Jan 2010

Granted

8 Jun 2010

Term ends

Not estimatedThe source records don’t support an estimate.

Classification31 codes

C07D 409/12
Containing two hetero rings: linked by a chain containing hetero atoms as chain links
A61P 1/04
Drugs for disorders of the alimentary tract or the digestive system: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of…
A61P 1/14
Drugs for disorders of the alimentary tract or the digestive system: prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics,…
A61P 3/00
Drugs for disorders of the metabolism

Fused cyclic compounds

Life of this patent

Abstract

Claims1

Fused cyclic compounds

Life of this patent

Abstract

Claims1